![Brent Pfeiffenberger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brent Pfeiffenberger
Chief Executive Officer at
CENTURY THERAPEUTICS, INC.
Net worth: 9 M $ as of 2026-05-30
Profile
Brent Pfeiffenberger is currently Chairman, President & Chief Executive Officer at Century Therapeutics, Inc. starting in 2025 and Independent Director at Corbus Pharmaceuticals Holdings, Inc. starting in 2026.
Former roles include Chief Operating Officer at Neogene Therapeutics, Inc. from 2021 to 2023 and Director at Medicines Australia.
Education includes an MBA from The Wharton School of the University of Pennsylvania and a doctorate from Duquesne University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-10 | 3,665,474 ( 2.03% ) | 9 M $ | 2026-05-30 |
Brent Pfeiffenberger active positions
| Companies | Position | Start |
|---|---|---|
| CENTURY THERAPEUTICS, INC. | Chief Executive Officer | 2023-12-03 |
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Director/Board Member | 2026-05-12 |
Former positions of Brent Pfeiffenberger
| Companies | Position | End |
|---|---|---|
Neogene Therapeutics, Inc.
 Neogene Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company that provides TCR therapies targeting neo-antigens in solid cancers | Chief Operating Officer | 2023-11-30 |
Medicines Australia
 Medicines Australia Pharmaceuticals: MajorHealth Technology Manufactures and supplies medicines and vaccines | Director/Board Member | - |
Training of Brent Pfeiffenberger
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
2
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Medicines Australia
Medicines Australia Pharmaceuticals: MajorHealth Technology Manufactures and supplies medicines and vaccines | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Corbus Pharmaceuticals Holdings, Inc.
 Corbus Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases | Health Technology |
Neogene Therapeutics, Inc.
Neogene Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company that provides TCR therapies targeting neo-antigens in solid cancers | Health Technology |
Century Therapeutics, Inc.
 Century Therapeutics, Inc. BiotechnologyHealth Technology Develops novel allogeneic living drugs for oncology that overcome the limitations of first-generation cell therapies | Health Technology |
- Stock Market
- Insiders
- Brent Pfeiffenberger
